Search

Dihexa is a synthetic angiotensin IV-derived peptide studied for its potential to promote synaptogenesis via hepatocyte growth factor / c-Met signaling. It is not FDA-approved and has no published human efficacy randomized controlled trials; evidence is preclinical, primarily in rodent models of cognitive impairment. It is investigated as a candidate for neurodegenerative and cognitive applications.